BRIEF published on 02/20/2026 at 20:20, 1 month 21 days ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 02/20/2026 at 20:20, 1 month 21 days ago IntegraGen : Bilan Annuel et Poursuite du Recentrage Stratégique Chiffre D'affaires Rentabilité Certifications Trésorerie Biopharma
PRESS RELEASE published on 02/20/2026 at 20:15, 1 month 21 days ago Informations privilégiées / Information sur chiffre d’affaires annuel IntegraGen annonce un chiffre d'affaires annuel de 5 M€ pour 2025, une trésorerie de 1,1 M€ et un recentrage sur les études cliniques biopharma Chiffre D'affaires Trésorerie Biopharma Études Cliniques IntegraGen
BRIEF published on 10/29/2025 at 17:50, 5 months 15 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 10/29/2025 at 17:50, 5 months 15 days ago IntegraGen : Résultats en Baisse, Réduction des Dépenses au 1er Semestre 2025 Résultats Financiers Trésorerie Génomique Réduction Coûts Certification CLIA/CAP
PRESS RELEASE published on 10/29/2025 at 17:45, 5 months 15 days ago Informations privilégiées / Communiqué sur comptes, résultats IntegraGen annonce une baisse de 20% des charges d’exploitation et une trésorerie de 1,7 M€ au 30 juin 2025. L'accent est mis sur l'exécution opérationnelle et le développement des activités cliniques/pharma Développement Trésorerie IntegraGen Certification CLIA/CAP Baisses Charges
BRIEF published on 07/02/2025 at 07:35, 9 months 12 days ago IntegraGen signale une baisse de ses ventes et de ses réserves de trésorerie Baisse Des Ventes Coûts Opérationnels IntegraGen Besoins De Financement Analyses Génomiques
BRIEF published on 07/02/2025 at 07:35, 9 months 12 days ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
PRESS RELEASE published on 07/02/2025 at 07:30, 9 months 12 days ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
PRESS RELEASE published on 07/02/2025 at 07:30, 9 months 12 days ago Informations privilégiées / Autres communiqués Communiqué de presse: Chiffre d’affaires de 2,5 M€ et trésorerie de 2,1 M€ au premier semestre 2025 pour IntegraGen. Baisse des activités et exploration stratégique pour assurer la continuité des opérations Chiffre D'affaires Stratégie Baisse Trésorerie IntegraGen
Published on 04/14/2026 at 09:05, 1 hour 54 minutes ago BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
Published on 04/14/2026 at 09:01, 1 hour 58 minutes ago Star Copper Fully Funded 15,000 Metre Drill Program Targets Maiden Resource in 2026
Published on 04/13/2026 at 23:15, 11 hours 44 minutes ago Relevant Gold Completes Strategic Financing; Embarks on Largest Drilling Program in Company History
Published on 04/13/2026 at 23:00, 11 hours 59 minutes ago Sterling Metals Announces Sale Of Sail Pond Project
Published on 04/13/2026 at 22:25, 12 hours 34 minutes ago Findev Inc. Announces Dividend Updates Ex-Dividend Date
Published on 04/14/2026 at 10:30, 28 minutes ago Baucor Boosts European Operations with Strategic Product Expansion
Published on 04/14/2026 at 10:00, 59 minutes ago ARTCLINE achieves milestone in septic shock: Patient recruitment for the ReActIF-ICE study successfully completed
Published on 04/14/2026 at 10:00, 59 minutes ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:57, 1 hour 2 minutes ago Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Published on 04/14/2026 at 09:43, 1 hour 15 minutes ago GFT named Leader in QKS Spark Matrix™ 2026 for Insurance Digital Transformation Services, Driving Faster, Lower-Risk Transformation
Published on 04/14/2026 at 08:30, 2 hours 29 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 15 hours 44 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 16 hours 44 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 16 hours 44 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 16 hours 49 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
